Nanayakkara S - Search Results

1

Differences in predictors of incident heart failure according to atherosclerotic cardiovascular disease status.

Dawson LP, Carrington MJ, Haregu T, Nanayakkara S, Jennings G, Dart A, Stub D, Kaye D. Dawson LP, et al. Among authors: nanayakkara s. ESC Heart Fail. 2023 Dec;10(6):3398-3409. doi: 10.1002/ehf2.14521. Epub 2023 Sep 9. ESC Heart Fail. 2023. PMID: 37688465 Free PMC article.

2

Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.

Rajapakse NW, Nanayakkara S, Kaye DM. Rajapakse NW, et al. Among authors: nanayakkara s. Pharmacol Ther. 2015 Oct;154:1-12. doi: 10.1016/j.pharmthera.2015.05.011. Epub 2015 May 16. Pharmacol Ther. 2015. PMID: 25989232 Review.

3

Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Yudi MB, Eccleston D, Andrianopoulos N, Farouque O, Duffy SJ, Brennan A, Reid C, Clark DJ, Ajani AE; Melbourne Interventional Group. Yudi MB, et al. Intern Med J. 2015 Oct;45(10):1032-7. doi: 10.1111/imj.12818. Intern Med J. 2015. PMID: 26013065

4

Management of heart failure with preserved ejection fraction: a review.

Nanayakkara S, Kaye DM. Nanayakkara S, et al. Clin Ther. 2015 Oct 1;37(10):2186-98. doi: 10.1016/j.clinthera.2015.08.005. Epub 2015 Sep 16. Clin Ther. 2015. PMID: 26385583 Review.

5

The use of the AVERT system to limit contrast volume administration during peripheral angiography and intervention.

Prasad A, Ortiz-Lopez C, Kaye DM, Byrne M, Nanayakkara S, Ahmed SH, Bailey SR, Mehran R, Sethi S, Banerjee A, Eng M. Prasad A, et al. Among authors: nanayakkara s. Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1228-33. doi: 10.1002/ccd.26155. Epub 2015 Sep 21. Catheter Cardiovasc Interv. 2015. PMID: 26389534

6

Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Kaye DM, Nanayakkara S, Vizi D, Byrne M, Mariani JA. Kaye DM, et al. Among authors: nanayakkara s. J Am Coll Cardiol. 2016 May 31;67(21):2554-6. doi: 10.1016/j.jacc.2016.03.539. J Am Coll Cardiol. 2016. PMID: 27230053 Free article. No abstract available.

7

Exercise Hemodynamics as a Predictor of Myocardial Recovery in LVAD Patients.

Segan LA, Nanayakkara SS, Leet AS, Vizi D, Kaye DM. Segan LA, et al. Among authors: nanayakkara ss. ASAIO J. 2017 May/Jun;63(3):342-345. doi: 10.1097/MAT.0000000000000490. ASAIO J. 2017. PMID: 27922882

8

Targets for Heart Failure With Preserved Ejection Fraction.

Nanayakkara S, Kaye DM. Nanayakkara S, et al. Clin Pharmacol Ther. 2017 Aug;102(2):228-237. doi: 10.1002/cpt.723. Epub 2017 Jun 23. Clin Pharmacol Ther. 2017. PMID: 28466986 Review.

9

Extended release oral milrinone as an adjunct to heart failure therapy.

Nanayakkara S, Bergin P, Mak V, Crannitch K, Kaye DM. Nanayakkara S, et al. Intern Med J. 2017 Aug;47(8):973-974. doi: 10.1111/imj.13503. Intern Med J. 2017. PMID: 28782207 No abstract available.

10

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age.

Nanayakkara S, Haykowsky M, Mariani J, Van Empel V, Maeder MT, Vizi D, Kaye DM. Nanayakkara S, et al. J Am Heart Assoc. 2017 Sep 22;6(9):e005434. doi: 10.1161/JAHA.116.005434. J Am Heart Assoc. 2017. PMID: 28939710 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters